Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.
Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia.
复制标题
DOI:
10.1001/jamaneurol.2014.1944
复制
发表时间:
2014-10
期刊:
影响因子:
29
通讯作者:
Nelson, Stanley F.
中科院分区:
文献类型:
--
作者:
Fogel, Brent L.;Lee, Hane;Deignan, Joshua L.;Strom, Samuel P.;Kantarci, Sibel;Wang, Xizhe;Quintero-Rivera, Fabiola;Vilain, Eric;Grody, Wayne W.;Perlman, Susan;Geschwind, Daniel H.;Nelson, Stanley F.
Cerebellar ataxias are a diverse collection of neurologic disorders with causes ranging from common acquired etiologies to rare genetic conditions. Numerous genetic disorders have been associated with chronic progressive ataxia and this consequently presents a diagnostic challenge for the clinician regarding how to approach and prioritize genetic testing in patients with such clinically heterogeneous phenotypes. Additionally, while the value of genetic testing in early-onset and/or familial cases seems clear, many patients with ataxia present sporadically with adult onset of symptoms and the contribution of genetic variation to the phenotype of these patients has not yet been established. To investigate the contribution of genetic disease in a population of patients with predominantly adult- and sporadic-onset cerebellar ataxia. We examined a consecutive series of 76 patients presenting to a tertiary referral center for evaluation of chronic progressive cerebellar ataxia. Next-generation exome sequencing coupled with comprehensive bioinformatic analysis, phenotypic analysis, and clinical correlation. We identified clinically relevant genetic information in more than 60% of patients studied (n = 46), including diagnostic pathogenic gene variants in 21% (n = 16), a notable yield given the diverse genetics and clinical heterogeneity of the cerebellar ataxias. This study demonstrated that clinical exome sequencing in patients with adult-onset and sporadic presentations of ataxia is a high-yield test, providing a definitive diagnosis in more than one-fifth of patients and suggesting a potential diagnosis in more than one-third to guide additional phenotyping and diagnostic evaluation. Therefore, clinical exome sequencing is an appropriate consideration in the routine genetic evaluation of all patients presenting with chronic progressive cerebellar ataxia.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
DOI:
10.1093/brain/awt315
发表时间:
2014-01
期刊:
Brain : a journal of neurology
影响因子:
--
作者:
Foley AR;Menezes MP;Pandraud A;Gonzalez MA;Al-Odaib A;Abrams AJ;Sugano K;Yonezawa A;Manzur AY;Burns J;Hughes I;McCullagh BG;Jungbluth H;Lim MJ;Lin JP;Megarbane A;Urtizberea JA;Shah AH;Antony J;Webster R;Broomfield A;Ng J;Mathew AA;O'Byrne JJ;Forman E;Scoto M;Prasad M;O'Brien K;Olpin S;Oppenheim M;Hargreaves I;Land JM;Wang MX;Carpenter K;Horvath R;Straub V;Lek M;Gold W;Farrell MO;Brandner S;Phadke R;Matsubara K;McGarvey ML;Scherer SS;Baxter PS;King MD;Clayton P;Rahman S;Reilly MM;Ouvrier RA;Christodoulou J;Züchner S;Muntoni F;Houlden H
通讯作者:
Houlden H
影响因子:
1.4
作者:
Fogel, Brent L.;Vickrey, Barbara G.;Browner, Carole H.
通讯作者:
Browner, Carole H.
影响因子:
7
作者:
Ng, PC;Henikoff, S
通讯作者:
Henikoff, S
影响因子:
14.5
作者:
Johnson, Janel O.;Gibbs, J. Raphael;Singleton, Andrew B.
通讯作者:
Singleton, Andrew B.